Labcorp (LH): financials, SEC filings and peers
Labcorp (LH) is a health care services company in the Health Care sector of the S&P 500, headquartered in Burlington, North Carolina.
It was founded in 1978 and joined the S&P 500 on November 1, 2004.
Its fiscal year ends in December, and its shares trade on the NYSE.
In its SEC filings it is classified as “Services-Medical Laboratories”.
Labcorp at a glance
- Revenue (12 months)
- $14.3B
- Revenue growth
- +6.4%
- Operating margin
- 10.4%
- Net income (12 months)
- $1.0B
- Free cash flow (12 months)
- $1.2B
- Cash
- $142M
- Debt
- $5.9B
- Diluted EPS (12 months)
- $12.09
Twelve months to June 30, 2026, from the 10-Q filed August 5, 2026.
Latest twelve months
Over the twelve months to June 30, 2026, Labcorp reported revenue of $14.3 billion, about the same as a year earlier (+6.4%).
Its operating margin was 10.4%, up 1.6 percentage points from a year earlier: for every $100 of sales, about $10 was left as operating profit.
Net income was $1.0 billion (7.0% of revenue), 31.3% higher than a year earlier.
Operating cash flow was $1.6 billion and capital spending $483 million, leaving free cash flow of $1.2 billion (8.1% of revenue).
At the end of the period it held $142 million in cash and $5.9 billion in debt, a net debt position of $5.7 billion.
The diluted share count fell 2.3% in a year, typically the result of buybacks.
Five-year trend
- Revenue went from $14.0 billion in fiscal 2020 to $14.0 billion in fiscal 2025, a decline of about 0.0% a year.
- Revenue has grown for 3 fiscal years in a row.
- Operating margin narrowed from 17.5% to 9.9% over the same years.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $13.1B | $11.9B | $12.2B | $13.0B | $14.0B |
| Revenue growth | -6.0% | -9.7% | 2.5% | 7.0% | 7.2% |
| Operating margin | 23.2% | 12.1% | 6.0% | 8.4% | 9.9% |
| Net income | $2.4B | $1.3B | $418M | $746M | $877M |
| Free cash flow | $2.7B | $1.5B | $874M | $1.1B | $1.2B |
| Diluted EPS | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 |
Fiscal years as reported in Labcorp’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 8-K filed September 22, 2026 — Regulation FD disclosure
- 8-K filed September 10, 2026 — Regulation FD disclosure
- 8-K filed August 28, 2026 — Regulation FD disclosure
- 8-K filed August 17, 2026 — Regulation FD disclosure
- 8-K filed August 14, 2026 — Executive or director change
- 10-Q filed August 5, 2026 — quarterly report
- 8-K filed July 30, 2026 — Earnings results
- 8-K filed July 10, 2026 — Regulation FD disclosure
Companies like Labcorp
Other S&P 500 companies in Health Care Services:
- CICignaBloomfield, Connecticut
- CVSCVS HealthWoonsocket, Rhode Island
- DGXQuest DiagnosticsSecaucus, New Jersey
- DVADaVitaDenver, Colorado
More from Health Care
Questions about Labcorp
Is Labcorp's revenue growing?
Yes. Revenue for the twelve months to June 30, 2026 was $14.3 billion, up 6.4% from a year earlier, according to its SEC filings.
Is Labcorp profitable?
Yes. It earned $1.0 billion in net income over the twelve months to June 30, 2026, a net margin of 7.0%.
Does Labcorp have more cash or more debt?
At June 30, 2026 it had $142 million in cash and $5.9 billion in debt, so more debt than cash.
When did Labcorp last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on August 5, 2026.
Which companies are similar to Labcorp?
In the S&P 500, Labcorp is grouped in Health Care Services within the Health Care sector. Cigna (CI), CVS Health (CVS), Quest Diagnostics (DGX), DaVita (DVA) are in the same group.
Understand the numbers
Source: Labcorp’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.